
Corvention Begins U.S. Rollout of KardiaPSI Catheter
Flagstaff-based medical device firm Corvention has initiated the limited commercial launch of its KardiaPSI balloon catheter in the United States. The milestone follows the platform's recent FDA 510(k) clearance, marking a shift toward broader clinical adoption for the structural heart technology after its successful domestic debut in Missouri.




























